The alternative treatment for peripheral neuropathy with the strongest evidence is not a supplement. It is diet and exercise aimed at the metabolic terrain. That approach improves nerve fiber density on skin biopsy. Other options have real but more limited support. They are intravenous alpha-lipoic acid, acetyl-L-carnitine, palmitoylethanolamide (PEA), acupuncture and high-concentration capsaicin.
People look for alternative treatments for peripheral neuropathy for a fair reason. The standard drugs treat the pain, not the nerve, and their average effect is modest. That is a real gap, and it is worth filling. It is also the gap the supplement industry has filled with a lot of confident marketing and very little published data.
What follows grades the non-drug options by the evidence that actually exists. It shows what has randomized trial support and what has weak support. It shows what failed when properly tested. And it shows the one approach that beats every bottle on the shelf.
Start with what the label “alternative” is hiding
Most people searching for alternative medicine for neuropathy have already been told nothing can be done about the cause. In a large share of cases that is not true. The cause simply was not looked for hard enough.
One study looked at 107 patients whose neuropathy had been called idiopathic (no known cause). Of these, 34% had impaired glucose tolerance, close to three times the rate in matched controls. In many of them, fasting glucose and HbA1c were normal. Only a two-hour oral glucose tolerance test found it.1 A separate series looked at 219 idiopathic neuropathy patients. Even those with fully normal blood sugar carried a heavy load of metabolic syndrome features. Lipid (blood fat) problems were especially common.2
So before spending money on supplements, make sure the workup was complete. It should include an OGTT, a full lipid panel, B12 with methylmalonic acid, thyroid studies, and a review of medications. The 11 hidden drivers of peripheral neuropathy covers the rest of that list. Did your nerve conduction study come back normal while your feet still burn? Then read small fiber peripheral neuropathy symptoms and testing before deciding that nothing was found.
What natural treatment has the strongest evidence for neuropathy?
Diet and exercise aimed at the metabolic terrain has better evidence than anything sold as a nerve supplement. And it is measured at the nerve, not on a questionnaire.
Thirty-two patients with impaired glucose tolerance and neuropathy got personalized diet and exercise counseling for one year. They had skin biopsies at the start and at 12 months. Intraepidermal nerve fiber density (nerve fibers in the skin) improved by 1.4 fibers per millimeter at the proximal site, higher on the leg. That gain tracked with less nerve pain.3 A separate study ran a 10-week supervised aerobic and resistance program. The patients had diagnosed diabetic peripheral neuropathy. It produced significant reductions in pain and nerve symptoms. Biopsies also showed more intraepidermal nerve fiber branching.4
A 2022 systematic review with meta-analysis pooled 41 randomized controlled trials. It found the evidence now supports a specific plan for diabetic peripheral neuropathy. The plan mixes endurance training with sensorimotor (balance) training. It helped balance measures and functional mobility. It helped peroneal and sural nerve conduction velocity. It also helped HbA1c.5
Nothing in the supplement aisle has that level of support. The practical program is in exercises for peripheral neuropathy in the feet.
Alpha-lipoic acid: real evidence, with an important qualifier
Alpha-lipoic acid is an antioxidant. It is the best-studied supplement in this field. A meta-analysis pooled four randomized, double-blind, placebo-controlled trials: ALADIN I, ALADIN III, SYDNEY and NATHAN II. Together they had 1,258 patients. After three weeks, the Total Symptom Score in the feet showed a 24.1% relative improvement versus placebo. Responder rates were 52.7% on alpha-lipoic acid against 36.9% on placebo. Pain, burning and numbness all improved. So did pinprick and touch-pressure feeling and ankle reflexes. Adverse event rates did not differ.6
The catch matters: that evidence is for 600 mg given intravenously, daily for three weeks. The oral capsules sold over the counter are not the same treatment, and their evidence is much weaker. If someone recommends a supplement based on “the ALADIN trials,” ask whether the study used the oral form.
Acetyl-L-carnitine: modest, in a specific population
Acetyl-L-carnitine improved pain, vibratory perception and measures of nerve regeneration in patients with chronic diabetic neuropathy in randomized trial data, with the clearest effect in those treated earlier in the disease course.7 It is a reasonable adjunct with a real, if modest, evidence base. It is not a substitute for treating the driver.
Palmitoylethanolamide: promising, and worth reading carefully
Palmitoylethanolamide, or PEA, is a naturally occurring fatty acid amide. A systematic review and meta-analysis pooled 11 double-blind randomized controlled trials. They covered 774 patients with chronic pain. Pain scores fell compared with the alternatives tested. No study tied major side effects to PEA.8 The authors noted that the best dose and delivery still need to be worked out. The trials also covered chronic pain in general, not neuropathy alone.
PEA is one of the supportive agents we use at our St. Louis clinic. We use it within a plan, not as a standalone answer.
Acupuncture: low-certainty evidence, genuine effect size
A 2025 systematic review and meta-analysis pooled 14 randomized trials. They had 1,169 participants. Compared with sham, acupuncture may cut pain in diabetic peripheral neuropathy by 1.44 cm on a 10 cm pain scale (visual analog scale). It may also reduce overall neurologic symptom severity. Adverse events showed little to no difference. The authors graded the certainty of that evidence as low.9
Low certainty does not mean it does not work. It means the trials were small or at risk of bias, and the estimate could move. Given how safe it is, acupuncture is a sound thing to try alongside treatment aimed at the cause.
Does capsaicin help neuropathy pain in the feet?
High-concentration capsaicin at 8% is a prescription patch, not a store-bought cream. People often find it while searching for natural options, because capsaicin comes from chili peppers. It works by switching off overactive pain fibers (nociceptive fibers) in the skin. There is published evidence of later nerve fiber regeneration along with the pain relief.10 We use it, and it is covered in the high-concentration capsaicin protocol.
Light-based therapies: mechanistic rationale, thin trial evidence
Photobiomodulation targets cytochrome c oxidase. That is an enzyme in the mitochondria, the cell’s power plants. It is meant to support energy production and blood flow in injured nerve tissue. We offer class 4 photobiomodulation, class 3B cold laser and whole-body infrared at the clinic. They are described on the services page.
Here is the honest state of the evidence. The reasoning behind how it works holds together. But the randomized trial base for diabetic peripheral neuropathy is still limited. Several systematic reviews have been registered and published only as protocols, not finished reviews. We use these therapies as add-ons within a plan built on finding and treating the cause. We do not present them as the treatment.
Which neuropathy supplements have failed in trials?
This section matters as much as the others. Benfotiamine is a fat-soluble form of thiamine (vitamin B1). It is sold widely for neuropathy. It was tested in a 12-month randomized, placebo-controlled, double-blind trial. The patients had type 2 diabetes and symptomatic polyneuropathy. It raised blood levels of all six thiamine analytes (markers) measured. That confirmed it was absorbed and doing something chemically in the body. But it had no significant effect on corneal nerve fiber length. It had no significant effect on the secondary morphometric, functional and clinical neuropathy outcomes. And it had no significant effect on quality of life.11
That is what a well-run negative trial looks like, and it is a useful yardstick. Ask this of any product sold for neuropathy: has it been tested this way, and what happened?
Which neuropathy treatments should you be skeptical of?
- Any product or program promising to cure, reverse or eliminate neuropathy. Nerve recovery is partial and slow, and it depends on the cause. A cure claim is a marketing claim.
- Proprietary “nerve support” blends that mix a dozen ingredients at doses below those used in any trial. No single ingredient reaches a studied dose.
- Fixed packages of sessions sold before a diagnosis. The number of treatments should follow clinical need and response, not a package bought in advance.
- High-dose vitamin B6. Excess B6 causes a sensory neuropathy in its own right. More is not better here.
- Anything that requires stopping your prescribed medication to work.
How we think about this
To us, alternative and complementary approaches are not a separate kind of medicine. They are treatments with an evidence base, to be graded like any other. Where the evidence supports something, we use it. Where it does not, we say so. And none of it replaces finding what is damaging the nerve. That order of steps is set out in the Regenerve Protocol. The full range of treatments is in peripheral neuropathy treatments for the feet.
Talk to your physician before starting any supplement. This matters most if you take anticoagulants (blood thinners), thyroid drugs or diabetes drugs. Note that alpha-lipoic acid can lower blood glucose.
Being evaluated in St. Louis
Regenerve is at 4477 Woodson Rd #104, St. Louis, MO 63134, minutes from St. Louis Lambert International Airport, and is led by Dr. Gurpreet Singh Padda, MD, MBA, MHP. The practice serves the St. Louis region, Missouri and Illinois. Electrodiagnostic testing is performed on site.
Call (314) 886-5739 or text (314) 886-5902, or email info@regenerve.com. Office hours are Monday through Thursday 9:00 to 16:00 and Friday 9:00 to 13:30. Details are on the contact page and the locations page.
Before buying anything, take the Nerve Damage Score. It is a five-question assessment that gives you a large-print report you can bring to any physician.
Alpha-lipoic acid has the most trial data of the supplements discussed here. The details are in alpha-lipoic acid for peripheral neuropathy: what the trials show.
Frequently asked questions
What is the best alternative treatment for peripheral neuropathy?
Diet and exercise aimed at the metabolic terrain has the strongest evidence, including measured regrowth of nerve fibers on skin biopsy. No supplement matches it. See exercises for peripheral neuropathy in the feet.
Does alpha-lipoic acid work for neuropathy?
The strong trial evidence is for 600 mg given intravenously over three weeks. That produced a 24.1% relative improvement in symptom scores versus placebo. Evidence for over-the-counter oral capsules is much weaker. See how sugar damages nerves.
Does acupuncture help neuropathy in the feet?
A meta-analysis of 14 randomized trials looked at acupuncture versus sham. It found acupuncture may reduce pain and neurologic symptom severity, with few adverse events. The certainty of that evidence was low. See peripheral neuropathy treatments for the feet.
Should I take benfotiamine for neuropathy?
A 12-month randomized placebo-controlled trial tested benfotiamine. It raised thiamine levels. But it had no significant effect on nerve structure, nerve function, clinical neuropathy measures or quality of life. See functional B12 deficiency and neuropathy.
Are supplements enough on their own?
No. Supplements address one input at a time. Neuropathy is driven by the whole metabolic environment. It is also driven by any nutritional, autoimmune, toxic or structural driver that is present. See the hidden drivers of peripheral neuropathy.
Can vitamins make neuropathy worse?
Yes. High-dose vitamin B6 can cause a sensory neuropathy of its own. So taking it without knowing your levels can add a driver instead of removing one. See functional B12 deficiency and neuropathy.
What is the number one supplement for neuropathy?
Alpha-lipoic acid is the best studied. But the strong results come from 600 mg given intravenously each day for three weeks, not from over-the-counter capsules. Acetyl-L-carnitine and palmitoylethanolamide (PEA) have real but more modest support. None of them matches diet and exercise aimed at the metabolic terrain. In studies, that approach has increased nerve fiber density measured on skin biopsy.
What exercises help neuropathy in the feet?
A 2022 review looked at 41 randomized trials in diabetic peripheral neuropathy. It supports combining endurance training with sensorimotor, or balance, training. That mix improved balance, functional mobility, nerve conduction velocity and HbA1c. A separate 10-week program used supervised aerobic and resistance training. Pain and nerve symptoms dropped. See exercises for peripheral neuropathy in the feet.
Does red light or laser therapy help neuropathy?
The reasoning behind it is sound, but the trial evidence is still thin. Photobiomodulation targets an enzyme in the mitochondria. The goal is to support energy production and blood flow in injured nerve tissue. Yet the randomized trial base for diabetic peripheral neuropathy remains limited. We offer class 4 photobiomodulation, class 3B cold laser and whole-body infrared as add-ons. They sit within a plan that treats the cause. They are not the treatment itself.
Is PEA safe to take for nerve pain?
One review pooled 11 double-blind randomized trials covering 774 people with chronic pain. No study tied major side effects to palmitoylethanolamide (PEA). Pain scores fell compared with the alternatives tested. The best dose is still not settled. And those trials covered chronic pain in general, not neuropathy alone. Talk to your physician before starting any supplement.
Sources
- Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care. 2001. PMID 11473085
- Smith AG, Rose K, Singleton JR. Idiopathic neuropathy patients are at high risk for metabolic syndrome. Journal of the Neurological Sciences. 2008. PMID 18606421
- Smith AG, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006. PMID 16732011
- Kluding PM, et al. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. Journal of Diabetes and its Complications. 2012. PMID 22717465
- Streckmann F, et al. Exercise and Neuropathy: Systematic Review with Meta-Analysis. Sports Medicine. 2022. PMID 34964950
- Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabetic Medicine. 2004. PMID 14984445
- Sima AAF, et al. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy. Diabetes Care. 2005. PMID 15616239
- Lang-Illievich K, et al. Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients. 2023. PMID 36986081
- Lan L, et al. Acupuncture for the Management of Chronic Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Current Pain and Headache Reports. 2025. PMID 40220243
- Anand P, et al. Reversing painful and non-painful diabetic neuropathy with the capsaicin 8% patch: clinical evidence for pain relief and restoration of function via nerve fiber regeneration. Frontiers in Neurology. 2022. PMID 36388188
- Ziegler D, et al. Effects of benfotiamine treatment over 12 months on morphometric, neurophysiological and clinical measures in type 2 diabetes patients with symptomatic polyneuropathy (BOND study). BMJ Open Diabetes Research & Care. 2026. PMID 41571333